INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
09/11/2024
Back to search
Official data from USPTO
FIRECREST
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
FIRECREST
ST13
US500000079105963Class
9, 41, 42
Filing
79105963
Registration
4329839
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
59
Latest update
09/11/2024
Trademark type
Word
Nice classes
9, 41, 42
Filing date
08/24/2010
Registration date
05/07/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/04/2024
Last transaction
01/04/2024
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
Dublin 18, IE
Examiner
HARDY LUDLOW, TARAH
Law office
M10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
ICON CLINICAL RESEARCH LIMITED
ICON CLINICAL RESEARCH LIMITED
FIRECREST CLINICAL LIMITED
Representatives
Rebecca E. McDougall Morgan, Lewis & Bockius LLP
Technical classification
Nice Classes
Class 9Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Scientificnauticalsurveyingphotographiccinematographicopticalweighingmeasuringsignalingchecking supervision and teaching apparatus and instrumentsprinters; apparatus for recordingtransmission or reproduction of sound or images; data processing equipment and computers; computer software for use in website development and managementcreation and compilation of spreadsheetsanalysis of datamaintenancedistribution and dissemination of data in the field of scientific researchclinical researchclinical studiesclinical trials and clinical treatmentsupport and guidance in medicine and surgery in the pharmaceuticalbiotechnology and medical device fieldsincluding site information and laboratory analysis in the field of pharmaceuticalsbiotechnology and medical devices; computer hardware and peripheral devices; computers; laptop computers; tablet computers; computer screens; computer firmware for use in the developmentanalysis and management of databases in the field of scientific researchclinical researchclinical studiesclinical trials and clinical treatmentsupport and guidance in medicine and surgery in the pharmaceuticalbiotechnology and medical device fields; downloadable electronic publications in the nature of scientific papersdocumentsreports pertinent to clinical studiesclinical dataclinical researchclinical treatmentsupport and guidance in medicine and surgery in relation to pharmaceuticals and clinical trials in the fields of pharmaceuticalsbiotechnology and medical devices; computer programs for use in preparation of data resultsanalysis of resultsdevelopment and delivery of training programs relating to clinical research and analysis; Computer software for use in collatinganalyzing data and reporting findings and site management in the fields of chemicalspharmaceuticals and clinical trials; pre-recorded magnetic data carriers featuring information and data in the field of scientific researchclinical researchclinical studiesclinical trials and clinical treatmentsupport and guidance in medicine and surgery in the pharmaceuticalbiotechnology and medical device fields
Class 41
Educational servicesproviding web-based training in the field of clinical studiesclinical dataclinical researchclinical treatmentsupport and guidance in medicine and surgeryin the pharmaceuticalbiotechnology and medical device fields; educational servicestraining in the field of clinical research and analysis and in the fields of chemicals and pharmaceuticals and the use of information technology in relation to clinical researchanalysischemicals and pharmaceuticals; educational servicesconducting and organizing seminarsconferencessymposiumscolloquium and discussion groups in relation to clinical researchanalysischemicals and pharmaceuticals; online and electronic publication of scientific papersdocuments and reports pertinent to a particular study all in connection with clinical studiesclinical data and clinical research in relation to pharmaceuticals and clinical trials in the pharmaceuticalbiotechnology and medical device fields
Class 42
Scientific research; Scientific and technological servicesresearch and design and laboratory analysis in the field of pharmaceuticals and clinical trials in the pharmaceuticalbiotechnology and medical device fields; Industrial research services in the field of pharmaceuticals and clinical trials in the pharmaceuticalbiotechnology and medical device fields; Design and development of computer hardware and software
Publications
History of USPTO decisions and trademark events.
59 publications found
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/05/2024
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
01/04/2024
71AG
REGISTERED-SEC.71 ACCEPTED
01/04/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/03/2024
ES71
TEAS SECTION 71 RECEIVED
05/05/2023
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
05/07/2022
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
10/24/2021
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
09/07/2021
INPC
INVALIDATION PROCESSED
09/07/2021
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
08/29/2021
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
12/29/2020
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
12/29/2020
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
12/16/2020
RNWL
INTERNATIONAL REGISTRATION RENEWED
10/01/2020
PR75
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
06/16/2020
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
04/09/2020
PR75
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
10/09/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/09/2019
ES75
TEAS SECTION 71 & 15 RECEIVED
10/06/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/05/2019
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/07/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/24/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/02/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/02/2016
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/30/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/14/2013
FIMP
FINAL DISPOSITION PROCESSED
08/14/2013
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/07/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
05/07/2013
GPNX
NOTIFICATION PROCESSED BY IB
03/10/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/19/2013
PUBO
PUBLISHED FOR OPPOSITION
02/19/2013
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/30/2013
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/30/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/30/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/14/2013
ALIE
ASSIGNED TO LIE
01/10/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/21/2012
XAEC
EXAMINER'S AMENDMENT ENTERED
12/21/2012
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/21/2012
GNEA
EXAMINERS AMENDMENT E-MAILED
12/21/2012
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/21/2012
CHLD
CHANGE OF OWNER RECEIVED FROM IB
12/21/2012
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/23/2012
GNFR
FINAL REFUSAL E-MAILED
06/23/2012
CNFR
FINAL REFUSAL WRITTEN
06/23/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/22/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/21/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/21/2012
RFNP
REFUSAL PROCESSED BY IB
01/09/2012
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/21/2011
RFRR
REFUSAL PROCESSED BY MPU
12/21/2011
MAFR
APPLICATION FILING RECEIPT MAILED
12/20/2011
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/18/2011
CNRT
NON-FINAL ACTION WRITTEN
12/17/2011
DOCK
ASSIGNED TO EXAMINER
12/16/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/16/2011
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/15/2011
Continuous trademark protection
Get notified about every new filing that threatens FIRECREST or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.